Quince Therapeutics (QNCX) Change in Acquisitions & Divestments (2019 - 2026)

Quince Therapeutics' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $12.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 7.69% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $57.0 million (down 25.48% YoY), while the FY2025 annual figure was $58.0 million, down 48.09% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $12.0 million, down from $13.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $49.1 million in Q3 2023, with the low at $11.0 million in Q3 2024.
• The 5-year median for Change in Acquisitions & Divestments is $18.0 million (2025), against an average of $22.1 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 263.37% in 2024, while the deepest fall reached 77.62% in 2024.
• Quince Therapeutics' Change in Acquisitions & Divestments stood at $27.0 million in 2022, then dropped by 1.12% to $26.7 million in 2023, then tumbled by 58.79% to $11.0 million in 2024, then climbed by 18.15% to $13.0 million in 2025, then decreased by 7.67% to $12.0 million in 2026.
• Business Quant data shows QNCX's Change in Acquisitions & Divestments at $12.0 million in Q1 2026, $13.0 million in Q4 2025, and $14.0 million in Q3 2025.